February 9, 2018 - Single gene testing has already been influencing clinical decision-making, such as in assessing breast cancer risk and how long a patient will need to stay on medication. But the whole genome will soon become an integral part of practitioners’ decision-making processes. How will genomics better inform providers on everything from risk and progression of disease, to individual response to treatment? Matt Yuill, M.D., Vice President, Quality and Risk Analytics at Interpreta, addresses this, and how barriers to leveraging genomics are being removed, in his latest article in Health IT Outcomes.
January 3, 2018 – Interpreta was named a Top 10 Genomics Solution Provider in 2017 by Pharma Tech Outlook Magazine and is featured in this month’s issue. Pharma Tech Outlook actively tracked 300 nominations, reviewed reports, industry news, social media and surveys with potential buyers, as well as conducted independent research, to arrive at the top 10. Read more about Interpreta being recognized for interpreting genomic, clinical, and FDA guidelines to tailor care for improved clinical outcomes.
November 3, 2017 - It’s predicted that the computing power required to use genomic data will soon be equal to – or more demanding than – the three other major generators of big data: astronomy, YouTube, and Twitter. With over 49,000 genetic tests for 9,000+ human conditions, the use of genomic data to inform and improve patient care decisions continues to grow. But to be effective, the data needs to be continuously interpreted alongside changes in clinical context and other factors.Read More
October 6, 2017 - The Sept/Oct issue of ClinicalOMICs talks about the Interpreta and higi partnership which, for the first time, integrates biometric data from higi health stations with clinical, claims, and genomic data from Interpreta to enable physicians and insurers to create personalized-care plans for patients. Read the full article on how the partnership is making direct-to-consumer (DTC) healthcare possible and empowering patients.
August 11, 2017 - Interpreta is featured as the cover story for the publication’s August issue, with company founders on the cover. Healthcare Tech Outlook recognizes Interpreta as “pioneering the future of clinical interpretation” through its ability to enable precision medicine.
July 19, 2017 - Physicians have been tailoring medical treatments to patients based on their specific genes, environment and lifestyle, for decades. Advances in technology and Pharmacogenomics are giving them even more data about patients to enable them to make the best decisionsRead More
April 3, 2017 - What is genomic medicine? And how is it primed to not only improve care, but make it more cost-effective? Interpreta’s Jaime Barea MD, Director of Medical Genetics; Tim Sayed MD, MBA, Vice President, Physician Engagement; and Benjamin Yu, MD PhD, Vice President, Medical Informatics and Genomics at Interpreta recently published an article on this topic in Becker’s Hospital Review.Read More
Bot technology can disrupt the pharma industry in many ways. One way is through delivery of content-on-demand based on a patient’s or provider’s interest in learning more about a drug or trial.Read More
December 02, 2015 - With a $215 million investment in the U.S.’s 2016 budget, precision medicine is clearly the future of healthcare. It’s critical in accelerating medical discoveries and providing clinicians with new tools, knowledge, and therapies to select appropriate treatments for individual patients.Read More
September 18, 2015 - In an invited meeting review, Interpreta Vice President of Clinical Informatics and Genomics, Dr. Benjamin Yu, reports on the industry landscape and positions of governmental, academic, professional, patient advocacy and manufacturing groups on clinical regulation of next generation sequencing (NGS).Read More
August 19, 2016 - Interpreta's Vice President of Physician Engagement, Tim Sayed, M.D., MBA, writes in For The Record magazine about the implications of precision medicine in practice and the role technology plays in implementing true precision medicine.
Read the article at Precision Medicine: It's ComplicatedRead More